Tumors

Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors

Phase 1 Study of E7090 in Subjects With Solid Tumor

HP Pyruvate MRI in Cancers

POWER UP: Participating Online While Exercising to Recover Using Play

ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling

Comparing 68Ga-CTR-FAPI and 18F-FDG PET/ CT in Cancer Detection

Perioperative Risk Study

CDK4/6 Tumor, Abemaciclib, Paclitaxel

A Study to Assess the Safety and Efficacy of ASP1650, a Monoclonal Antibody Targeting Claudin 6 (CLDN6), in Male Subjects With Incurable Platinum Refractory Germ Cell Tumors

A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid Tumors

Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction

A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid Tumors

Cohort of Tumors With POLE/D1 Mutation

Point of Care 3D Ultrasound for Various Applications: A Pilot Study

A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4

The Drug Rediscovery Protocol (DRUP Trial)

A Novel 68Ga Labeled FAP Ligand PET/CT in Patients With Various Malignant Tumors

A Trial of Lenvatinib (E7080) Plus Pembrolizumab in Participants With Selected Solid Tumors

A Phase I Study of PLX038 in Patients With Advanced Solid Tumors